Open original FDA record ↗Recall record
- FDA identifier
- Z-1399-05
- Company in FDA record
- Abbott Laboratories MPG
- FDA classification date
- Aug 24, 2005
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
False Positive results may be obtained with the identified lot of list 3A60-16 when using a negative patient sample or a negative control.
Source facts
- Action
- Abbott notified their affiliates in all eight countries via e-mail on 8/7/05. Each Abbott international country organization is responsible for translating the customer letter, contacting customers and determining the method of effectiveness checks based on their country requirements. The recall letters inform the accounts of the false positive results, and were requested to return any remaining inventory of the affected lots to Abbott in Germany.
- Initiated
- 2005-08-07
- Root cause
- Other
- Terminated
- 2006-03-27
- Distribution
- This product is not distributed in the U.S. It was distributed internationally to Canada, Germany, Honduras, Nicaragua, the Bahamas, the Philippines (via Singapore), New Zealand, and Uruguay
- Recall number
- Z-1399-05
- Recall status
- Terminated
- CDRH record ID
- 41038
- FDA classified
- 2005-08-24
- Recall event number
- 32895